- Available history
- No dated observations
- Data captured
IPO Date coverage
BeOne Medicines Ltd. (ONC). What the retained company guidance contains and how many periods can be scored.
- Legal name: Value BeOne Medicines Ltd..
- Ticker: Value ONC.
- Exchange: Value Nasdaq.
- IPO date: Value 3 Feb 2016.
| Measure | Value |
|---|---|
| Legal name | BeOne Medicines Ltd. |
| Ticker | ONC |
| Exchange | Nasdaq |
| IPO date | 3 Feb 2016 |
| Country | Cayman Islands |
| Final IPO prospectus | Form 424B4 filed 2016-02-03, accession 0001047469-16-009999 |
| Registration statement | Form S-1 filed 2015-10-16, accession 0001047469-15-007900 |
| Country of operation (business address) | Switzerland |
| Business address | C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051, Switzerland |
| Mailing address | C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051, Switzerland |
| Industry (SIC) | 2834 Pharmaceutical Preparations |
| Fiscal year end | 12-31 |
| Filer category | Large accelerated filer |
| Listed stock (Section 12(b)) | American Depositary Shares, each representing 13 Ordinary Shares, par value $0.0001 per share · ONC · The Nasdaq Global Select Market 10-Q filed 2026-08-05 cover |
| Shell company | No 10-Q filed 2026-08-05 cover |
| Smaller reporting company | No 10-Q filed 2026-08-05 cover |
| Emerging growth company | No 10-Q filed 2026-08-05 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-05 cover |
| Well-known seasoned issuer | Yes 10-K filed 2026-02-26 cover |
| Voluntary filer | No 10-K filed 2026-02-26 cover |
| Former names | BeiGene, Ltd. (2015-08-28 to 2025-05-27) |
| First EDGAR filing | 2015-08-28 (DRS) |
| SEC CIK | 1651308 |
| EIN | 981209416 |
| Phone | 41-616851900 |